Acciones MusclePharm Corporation Other OTC
Acciones
MSLP
US6273352012
Holding Companies
Ventas 2020 | 64,44 M 59,37 M | Ventas 2021 | 50,04 M 46,1 M | Capitalización | 13,35 M 12,3 M |
---|---|---|---|---|---|
Resultado Neto 2020 | 3 M 2,76 M | Resultado Neto 2021 | -12 M -11,06 M | VE / Ventas 2020 | 0,27 x |
Deuda neta 2020 | 10,43 M 9,61 M | Deuda neta 2021 | 15,93 M 14,68 M | VE / Ventas 2021 | 0,59 x |
P/E ratio 2020 |
2,55
x | P/E ratio 2021 |
-1,03
x | Empleados | - |
Rendimiento 2020 * |
-
| Rendimiento 2021 |
-
| Flotante | 88,94 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Eric Hillman
CEO | Chief Executive Officer | - | 13/02/23 |
Eric Chin
DFI | Director of Finance/CFO | 44 | 17/06/22 |
Chairman | 53 | 26/08/15 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Eric Hillman
CEO | Chief Executive Officer | - | 13/02/23 |
Michael Heller
BRD | Director/Board Member | 48 | 19/01/21 |
Chairman | 53 | 26/08/15 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+152,51 % | 6613,57 M | |
+2,19 % | 982 M | |
+41,91 % | 872 M | |
+30,42 % | 858 M | |
+1,82 % | 664 M | |
+2,33 % | 642 M | |
-.--% | 600 M | |
+3,61 % | 503 M | |
-.--% | 500 M |